Renaud La Joie

Navedeno

	Vse	Od leta 2020
Navedbe	16864	13144
indeks h	66	59
indeks i10	139	138

3300

1650

825

2475

2013201420152016201720182019202020212022202320242025100 194 294 472 619 788 1100 1464 2178 2405 2906 3296 851

Javni dostop

Prikaži vse

150 člankov

5 člankov

na voljo

ni na voljo

Na podlagi zahtev v povezavi s financiranjem

Soavtorji

Gil RabinoviciPreverjeni e-poštni naslov na ucsf.edu
Gael ChételatResearcher (Inserm, French institute for biomedical research)Preverjeni e-poštni naslov na cyceron.fr
Maria Luisa Gorno-TempiniProfessor of Neurology and Psychiatry UCSFPreverjeni e-poštni naslov na ucsf.edu
William SeeleyProfessor of Neurology and Pathology, University of California, San FranicscoPreverjeni e-poštni naslov na ucsf.edu
Leonardo IaccarinoEli Lilly and Company, AvidPreverjeni e-poštni naslov na lilly.com
Suzanne BakerLawrence Berkeley National LabPreverjeni e-poštni naslov na lbl.gov
Adam BoxerUCSF Memory and Aging CenterPreverjeni e-poštni naslov na ucsf.edu
Rik OssenkoppeleVU University Medical Center Amsterdam & Lund UniversityPreverjeni e-poštni naslov na vumc.nl
Audrey PerrotinInserm U1077Preverjeni e-poštni naslov na cyceron.fr
Lea Tenenholz GrinbergUniversity of California, San FranciscoPreverjeni e-poštni naslov na ucsf.edu
Oskar HanssonProfessor of Neurology, Lund UniversityPreverjeni e-poštni naslov na med.lu.se
Jacob VogelLund UniversityPreverjeni e-poštni naslov na med.lu.se
Zachary MillerAssociate Professor of Neurology, UCSF Memory and Aging CenterPreverjeni e-poštni naslov na memory.ucsf.edu
Amelia StromHarvard-MIT Health Sciences and TechnologyPreverjeni e-poštni naslov na mit.edu
Kaitlin CasalettoUniversity of California, San FranciscoPreverjeni e-poštni naslov na ucsf.edu
Salvatore SpinaAssociate Professor of Neurology, University of California San FranciscoPreverjeni e-poštni naslov na gbhi.org
David N. Soleimani-MeigooniUniversity of California, San FranciscoPreverjeni e-poštni naslov na ucsf.edu
Ruben SmithLund UniversityPreverjeni e-poštni naslov na med.lu.se
Alexandre Bejanin (ORCID:0000-0002...Institut de Recerca Sant Pau - Centre CERCA, Barcelona, Spain.Preverjeni e-poštni naslov na santpau.cat
Niklas Mattsson-Carlgren, MD, PhDLund UniversityPreverjeni e-poštni naslov na med.lu.se

Spremljaj

Renaud La Joie

Memory and Aging Center; Department of Neurology; University of California, San Francisco

Preverjeni e-poštni naslov na ucsf.edu - Domača stran

Alzheimer's disease neuroimaging hippocampus brain networks memory


Naslov Razvrsti po navedbah Razvrsti po letniku Razvrsti po naslovu	Navedeno Navedeno	Leto
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease A Bejanin, DR Schonhaut, R La Joie, JH Kramer, SL Baker, N Sosa, ... Brain 140 (12), 3286-3300, 2017	742	2017
Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ... Nature medicine 26 (3), 387-397, 2020	656	2020
Four distinct trajectories of tau deposition identified in Alzheimer’s disease JW Vogel, AL Young, NP Oxtoby, R Smith, R Ossenkoppele, ... Nature Medicine 27 (5), 871-881, 2021	608	2021
The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features R Ossenkoppele, YAL Pijnenburg, DC Perry, BI Cohn-Sheehy, ... Brain 138 (9), 2732-2749, 2015	586	2015
Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET R La Joie, AV Visani, SL Baker, JA Brown, V Bourakova, J Cha, ... Science translational medicine 12 (524), eaau5732, 2020	513	2020
Why musical memory can be preserved in advanced Alzheimer’s disease JH Jacobsen, J Stelzer, TH Fritz, G Chételat, R La Joie, R Turner Brain 138 (8), 2438-2450, 2015	446	2015
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease A Maass, S Landau, SL Baker, A Horng, SN Lockhart, R La Joie, ... Neuroimage 157, 448-463, 2017	445	2017
Discriminative Accuracy of [18F] flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders R Ossenkoppele, GD Rabinovici, R Smith, H Cho, M Schöll, O Strandberg, ... JAMA 320 (11), 1151-1162, 2018	433	2018
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation S Villeneuve, GD Rabinovici, BI Cohn-Sheehy, C Madison, N Ayakta, ... Brain 138 (7), 2020-2033, 2015	418	2015
Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease G Chételat, R La Joie, N Villain, A Perrotin, V de La Sayette, F Eustache, ... NeuroImage: Clinical 2, 356-365, 2013	417	2013
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study EH Thijssen, R La Joie, A Strom, C Fonseca, L Iaccarino, A Wolf, S Spina, ... The Lancet Neurology 20 (9), 739-752, 2021	402	2021
Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia R La Joie, A Perrotin, L Barré, C Hommet, F Mézenge, M Ibazizene, ... Journal of Neuroscience 32 (46), 16265-16273, 2012	400	2012
Structural imaging of hippocampal subfields in healthy aging and Alzheimer’s disease R De Flores, R La Joie, G Chételat Neuroscience 309, 29-50, 2015	383	2015
Relationships between years of education and gray matter volume, metabolism and functional connectivity in healthy elders EM Arenaza-Urquijo, B Landeau, R La Joie, K Mevel, F Mézenge, ... Neuroimage 83, 450-457, 2013	344	2013
Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: towards a harmonized segmentation protocol PA Yushkevich, RSC Amaral, JC Augustinack, AR Bender, JD Bernstein, ... Neuroimage 111, 526-541, 2015	329	2015
Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia R La Joie, A Perrotin, V De La Sayette, S Egret, L Doeuvre, S Belliard, ... NeuroImage: Clinical 3, 155-162, 2013	310	2013
Using PET with ¹⁸F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment V Camus, P Payoux, L Barré, B Desgranges, T Voisin, C Tauber, ... European journal of nuclear medicine and molecular imaging 39, 621-631, 2012	279	2012
Longitudinal tau accumulation and atrophy in aging and alzheimer disease TM Harrison, R La Joie, A Maass, SL Baker, K Swinnerton, L Fenton, ... Annals of neurology 85 (2), 229-240, 2019	275	2019
Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease R Ossenkoppele, BI Cohn‐Sheehy, R La Joie, JW Vogel, C Möller, ... Human brain mapping 36 (11), 4421-4437, 2015	255	2015
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission … R Ossenkoppele, R Smith, N Mattsson-Carlgren, C Groot, A Leuzy, ... JAMA neurology 78 (8), 961-971, 2021	240	2021

Sistem trenutno ne more izvesti postopka. Poskusite znova pozneje.

Članki 1–20

Št. navedb na leto

Podvojene navedbe

Združene navedbe

Dodajanje soavtorjevSoavtorji

Spremljaj

Navedeno

Soavtorji